Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000116

COO and Secretary sold 10,000 shares at an average $42.27 ($422,736)

From the SEC's structured data for this filing

Trades in this filing

Schuth Alexander O. · COO and Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-12-06 Sale : show line 1 in the form −2,800 $41.82 $117,096 460,283 I
2021-12-06 Sale : show line 2 in the form −7,200 $42.45 $305,640 453,083 I
Open-market sales · 10,000 sh · avg $42.27 · $422,736
Loading xslF345X03/wf-form4_163900292998153.xml…